Blepharoptosis: Clinical Trials

72 trials for Blepharoptosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

37 completed, 15 unknown, 9 recruiting, 4 terminated. 32 Not applicable, 12 Phase 4, 7 Phase 2, 7 Phase 3, 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable32Completed 13, Unknown 11, Recruiting 4, Terminated 3, Not yet recruiting 1
Phase 412Completed 7, Not yet recruiting 2, Withdrawn 2, Unknown 1
Phase 27Completed 3, Unknown 2, Terminated 1, Withdrawn 1
Phase 37Completed 3, Unknown 2, Recruiting 1, Terminated 1
Early Phase 12Completed 2
Phase 12Completed 2

Follow Blepharoptosis: new trials by email Literature Review of Blepharoptosis trials Research Report on Blepharoptosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients
brimonidine tartrate ophthalmic solution 0.025%, sterile balanced saline solution - Glaucoma, Glaucoma, Open-Angle
Phase 4Not yet recruitingTulane University602027-11-012026-10-13
Upneeq vs. Lumify Ptosis
Oxymetazoline 0.1% (Upneeq), Brimonidine 0.025% (Lumify) - Acquired Ptosis
Phase 4Not yet recruitingDuke University502026-12-012026-05-22
Effect of Suture Material on Eyelid Height Stability After Anterior White-Line Advancement for Aponeurotic Ptosis.
Anterior white-line advancement using an ABSORBABLE suture (POLYSORB 5-0). RED CODE., Anterior white-line advancement using a NON-ABSORBABLE suture (POLYPROPYLENE 5-0). BLUE CODE. - Blepharoptosis
Not applicableNot yet recruitingInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz582026-10-012026-10-01
Blepharoptosis After Repeated Intravitreal Anti-VEGF Injections: A Prospective Study
Repeated intravitreal anti-VEGF injection with eyelid speculum - Blepharoptosis, Age-Related Macular Degeneration
RecruitingAbdulkadir Küçük602026-09-252026-11-02
Comparative Study of Ziplyft Treatment vs. Traditional Blepharoplasty for Upper Eyelid Rejuvenation
Ziplyft Device, Comparator Arm: Standard Blepharoplasty - Dermatochalasis of Upper Eyelid, Ptosis, Eyelid
Not applicableRecruitingOsheru Inc.502025-12-082025-11-26
Anterior Versus Posterior White Line Advancement Technique in the Correction of Aponeurotic Ptosis
Anterior White Line Advancement Surgery, Posterior White Line Advancement Surgery - Ptosis, Eyelid
Not applicableRecruitingInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz542025-06-012025-10-07
A Prospective Cohort Study on Visual Function and Psychological Conditions Before and After Surgery for Congenital Ptosis
Ptosis
RecruitingZhongshan Ophthalmic Center, Sun Yat-sen University732025-06-012026-04-16
Capturing Key MG-symptoms Using Smartphone Recordings.
Myasthenia Gravis, Fatigue
RecruitingLeiden University Medical Center2252025-03-182026-07-08
A Pharmacokinetics (PK) Study in Healthy Adults
STN1013800 ophthalmic solution - Blepharoptosis
Early Phase 1CompletedSanten Pharmaceutical Co., Ltd.82025-03-172025-04-22
A Study in Chinese Patients With Acquired Blepharoptosis
STN1013800 ophthalmic solution, STN1013800 ophthalmic solution Liquid Base, without STN1013800 - Blepharoptosis
Phase 3RecruitingSanten Pharmaceutical Co., Ltd.1802024-10-222026-05-15
Phenylephrine Versus Eyelid Taping for Muller's Muscle-Conjunctival Resection (MMCR) Evaluation
Phenylephrine Ophthalmic, Eyelid Tape - Ptosis, Eyelid
Phase 4CompletedUniversity of Miami182024-03-192025-08-22
Red Light Ptosis Proof-of-Concept
Near-infrared light - Mitochondrial Diseases, Blepharoptosis
Not applicableUnknownUniversity College, London102024-02-082024-03-05
Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis
Oxymetazoline 0.1% (Pf) Oph Soln Ud, Preservative free lubricating drops - Blepharoptosis, Synkinesis
Phase 3CompletedMilton S. Hershey Medical Center362024-01-112026-03-09
A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis
Feedback-enabled magnetic device - Blepharoptosis, Device Usability
Not applicableRecruitingE-DA Hospital402023-04-012026-09-23
LEV102 Topical Gel in Acquired Blepharoptosis
LEV102 1.0%, LEV102 2.0%, Vehicle - Acquired Blepharoptosis
Phase 1 / Phase 2CompletedLevation Pharma, Ltd.332023-02-232024-11-13
Performance and Safety Assessment of SPRING THREAD® Elastic Tensor Thread in Patients With Mild to Moderate Facial Ptosis.
Ptosis, Ptosis, Mild
Active not recruiting1st SurgiConcept992023-02-162026-09-30
Effect of Upper Eyelid Surgeries on Corneal Characteristics
levator muscle resection surgery, Müller's muscle-conjuctival resection surgery, full-thickness anterior blepharotomy surgery - Eyelid Diseases, Ptosis, Eyelid
CompletedNational Taiwan University Hospital132023-02-062024-11-25
Brimonidine for Intraoperative Hemostasis
Brimonidine Topical - Dermatochalasis of Eyelid, Ptosis, Eyelid
Phase 4WithdrawnUniversity of Louisville2022-05-262025-01-15
Fibrin Sealant in Eyelid Surgery
Tisseel - Blepharoptosis, Ecchymosis; Eyelid
Phase 2 / Phase 3UnknownUniversity of Calgary302022-05-012022-05-03
Natural History of Oculo-Pharyngeal Muscular Dystrophy (OPMD) - Israel National OPMD Registry
Non-interventional observational study - Oculopharyngeal Muscular Dystrophy (OPMD)
RecruitingSheba Medical Center3002022-02-012025-08-28

Showing 20 of 72. Sign in to see all of them.

Narrower conditions

Cutis Laxa (7)  ·  Ectropion (5)  ·  Entropion (5)  ·  Eyelid Diseases (3)  ·  Myasthenia Gravis (3)  ·  Brain Injuries, Traumatic (2)  ·  Deglutition Disorders (2)  ·  Esotropia (2)  ·  Exotropia (2)  ·  Facial Paralysis (2)  ·  Glaucoma (2)  ·  Lagophthalmos (2)  ·  Macular Degeneration (2)  ·  Muscle Weakness (2)

Broader conditions

Eye Diseases (72)  ·  Eyelid Diseases (69)  ·  Nervous System Diseases (14)  ·  Pathological Conditions, Signs and Symptoms (14)  ·  Signs and Symptoms (12)  ·  Neurologic Manifestations (10)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (9)  ·  Genetic Diseases, Inborn (9)  ·  Connective Tissue Diseases (7)  ·  Skin Diseases (7)  ·  Skin Diseases, Genetic (7)  ·  Skin and Connective Tissue Diseases (7)  ·  Cranial Nerve Diseases (6)  ·  Neuromuscular Diseases (6)  ·  Ocular Motility Disorders (6)

Interventions

Brimonidine Tartrate (4)  ·  Lidocaine (3)  ·  Oxymetazoline (3)  ·  Bupivacaine (2)  ·  Epinephrine (2)  ·  Saline Solution (2)  ·  Blepharoplasty (1)  ·  Botulinum Toxins, Type A (1)  ·  Deoxycytidine (1)  ·  Drug Implants (1)  ·  Fibrin Tissue Adhesive (1)  ·  Indicator Dilution Techniques (1)  ·  Ophthalmic Solutions (1)  ·  Sodium Chloride (1)  ·  Thymidine (1)

Sponsors

Sheba Medical Center (4)  ·  University of Miami (4)  ·  Massachusetts Eye and Ear Infirmary (3)  ·  Meir Medical Center (3)  ·  RVL Pharmaceuticals, Inc. (3)  ·  Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (2)  ·  Santen Pharmaceutical Co., Ltd. (2)  ·  University of California, San Francisco (2)  ·  1st SurgiConcept (1)  ·  Abdulkadir Küçük (1)  ·  Aesculap AG (1)  ·  Ain Shams University (1)  ·  Assiut University (1)  ·  Augenklinik LMU (1)  ·  Aurolab (1)

Countries

United States (29)  ·  Israel (9)  ·  Canada (4)  ·  China (4)  ·  Egypt (4)  ·  Spain (4)  ·  Brazil (3)  ·  France (3)  ·  United Kingdom (3)  ·  Germany (2)  ·  Taiwan (2)  ·  Croatia (1)  ·  Czechia (1)  ·  India (1)  ·  Indonesia (1)

Top investigators

Viviana Patricia Lezcano Carduz, MD (2)  ·  Abdel Khalek I Elsaadany, PhD (1)  ·  Alan B Scott, MD (1)  ·  Albert Y Wu, MD PhD (1)  ·  Amr Awara, MD (1)  ·  Angelino J Cariello, MD (1)  ·  Anna Schuh (1)  ·  Anne Barmettler, MD (1)  ·  Arik Nemet, Dr (1)  ·  Bradley P Bengtson, MD (1)  ·  Christopher Compton, MD (1)  ·  Christopher Dermarkarian (1)  ·  Chuck Slonim, MD (1)

Results publications

PMID 12063480, PMID 12930337, PMID 15871316, PMID 20126486, PMID 36996503, PMID 38408310, PMID 39932468, PMID 40671431, PMID 40911819, PMID 42024579

NIH funding

2015 (1), 2019 (1), R01EY029437 (1)